Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03768128 · ClinicalTrials.gov registry record
Safety and Performance of the Journey™ II UNI Unicompartmental Knee System
A clinical trial, sponsored by Smith & Nephew.
- Completed
- Registry status
- 154
- Enrollment target
NCT03768128: Completed study, sponsored by Smith & Nephew.
NCT03768128 is a clinical trial that has completed, run by Smith & Nephew. The registered enrollment target is 154 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03768128 has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will be evaluated.
Interventions
- DEVICE Journey™ II UNI Unicompartmental Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2018-08-10 |
| Est. Completion | 2025-05-19 |
What the finished NCT03768128 record still lists
NCT03768128 is an observational study that tracks outcomes without assigning an intervention. The registered 154 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Journey™ II UNI Unicompartmental Knee System is the first listed.
NCT03768128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03768128 about?
NCT03768128 is a clinical study titled "Safety and Performance of the Journey™ II UNI Unicompartmental Knee System". This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will...
What is the current status of trial NCT03768128?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2018-08-10. Estimated completion is 2025-05-19.
What interventions are being tested in trial NCT03768128?
The interventions under investigation include: Journey™ II UNI Unicompartmental Knee System (DEVICE).
Who is sponsoring clinical trial NCT03768128?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04300998 · 154 participants
Study of CAR-T Therapy in Older Patients
- NCT04597372 · 154 participants · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
- NCT05294042 · 154 participants · NA
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
- NCT05512390 · 154 participants · Phase 1
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI